About this event:

Date: May 22, 2025

Time: 11 am EDT | 8 am PDT |

5 pm CEST

Duration: 60 minutes

This webinar outlines a strategic framework for advancing late-stage biopharmaceutical manufacturing through integrated innovation and platform-based solutions. Focusing on both upstream and downstream processes, WuXi Biologics demonstrates how media optimization and process intensification can increase drug substance by multiple folds, while reducing raw material costs and cycle time.

One example includes the use of WuXiUI™ for high cell density fed batch cultures, combined with intensified harvest techniques and innovative chromatography modes. Process analytical technology (PAT), powered by advanced Raman modeling, enables real-time monitoring and dynamic control to further improve process performance and robustness.

WuXi Biologics' systematic analytical strategy, anchored in advanced characterization approaches such as forced degradation and stability testing, ensures product comparability following process improvements.

Case studies illustrate the effectiveness of this approach in reducing the cost of goods sold by 60% to 80%, establishing a new paradigm for high performing commercially viable biologics manufacturing.